研究者
J-GLOBAL ID：200901069676760499
更新日: 2020年09月01日
小川 晃平
オガワ コウヘイ | Ogawa Kohei
この研究者にコンタクトする
直接研究者へメールで問い合わせることができます。
所属機関・部署：
愛媛大学
愛媛大学 について
「愛媛大学」ですべてを検索
競争的資金等の研究課題 (1件)：
-
論文 (85件)：
Kosuke Endo, Taku Iida, Shintaro Yagi, Atsushi Yoshizawa, Yasuhiro Fujimoto, Kohei Ogawa, Yasuhiro Ogura, Akira Mori, Toshimi Kaido, Shinji Uemoto. Impact of preoperative uncontrollable hepatic hydrothorax and massive ascites in adult liver transplantation. SURGERY TODAY. 2014. 44. 12. 2293-2299
Yoshihide Ueda, Toshimi Kaido, Takashi Ito, Kohei Ogawa, Atsushi Yoshizawa, Yasuhiro Fujimoto, Akira Mori, Aya Miyagawa-Hayashino, Hironori Haga, Hiroyuki Marusawa, et al. Chronic Rejection Associated with Antiviral Therapy for Recurrent Hepatitis C after Living-Donor Liver Transplantation. TRANSPLANTATION. 2014. 97. 3. 344-350
Kazutaka Tanabe, Shinichi Sugimoto, Toyonari Kubota, Keiko Kubota, Shoichi Kageyama, Michio Takamura, Kohei Ogawa, Hiroshi Takeda, Koji Hashimoto, Atsuo Tokuka. A case of suspected abdominal compartment syndrome due to spontaneous rupture of the stomach in an adult. Japanese Journal of Gastroenterological Surgery. 2014. 47. 2. 92-99
T. Hori, S. Yagi, Y. Okamua, T. Iida, K. Ogawa, H. Tanaka, S. Kageyama, H. Hirao, T. Hata, I. Kirino, et al. How to successfully resect 70 % of the liver in pigs to model an extended hepatectomy with an insufficient remnant or liver transplantation with a small-for-size graft. Surgery Today. 2014. 1-7
Miwa Uesugi, Mio Hosokawa, Haruka Shinke, Emina Hashimoto, Tamotsu Takahashi, Tomoki Kawai, Kazuo Matsubara, Kohei Ogawa, Yasuhiro Fujimoto, Shinya Okamoto, et al. Influence of Cytochrome P450 (CYP) 3A4*1G Polymorphism on the Pharmacokinetics of Tacrolimus, Probability of Acute Cellular Rejection, and mRNA Expression Level of CYP3A5 Rather than CYP3A4 in Living-Donor Liver Transplant Patients. BIOLOGICAL & PHARMACEUTICAL BULLETIN. 2013. 36. 11. 1814-1821
もっと見る
MISC (6件)：
T. Hori, M. Ueda, F. Oike, Y. Ogura, K. Ogawa, J. H. Nguyen, Y. Yonekawa, Y. Takada, H. Egawa, A. Yoshizawa, et al. Graft Loss and Poor Outcomes After Living-Donor Liver Transplantation Owing to Arterioportal Shunts Caused by Liver Needle Biopsies. TRANSPLANTATION PROCEEDINGS. 2010. 42. 7. 2642-2644
A Yoshizawa, S Sakamoto, K Ogawa, M Kasahara, K Uryuhara, F Oike, M Ueda, Y Takada, H Egawa, K Tanaka. New protocol of immunosuppression for liver transplantation across ABO barrier: The use of Rituximab, hepatic arterial infusion, and preservation of spleen. TRANSPLANTATION PROCEEDINGS. 2005. 37. 4. 1718-1719
M Ueda, H Egawa, K Ogawa, K Uryuhara, Y Fujimoto, M Kasahara, Y Ogura, K Kozaki, Y Takada, K Tanaka. Portal vein complications in the long-term course after pediatric living donor liver transplantation. TRANSPLANTATION PROCEEDINGS. 2005. 37. 2. 1138-1140
Zhao, X, T Koshiba, Y Fujimoto, J Pirenne, A Yoshizawa, T Ito, H Kamei, K Jobara, K Ogawa, K Uryuhara, et al. Proinflammatory and antiinflammatory cytokine production during ischemia-reperfusion injury in a case of identical twin living donor liver transplantation using no immunosuppression. TRANSPLANTATION PROCEEDINGS. 2005. 37. 1. 392-394
H Ali, H Egawa, K Uryuhara, K Ogawa, M Kasahara, M Ueda, H Marusawa, M Nabeshima, K Tanaka. Prevention of hepatitis B virus recurrence after living donor liver transplantation. TRANSPLANTATION PROCEEDINGS. 2004. 36. 9. 2764-2767
もっと見る
経歴 (1件)：
京都大学 医学部附属病院 その他
※ J-GLOBALの研究者情報は、
researchmap
の登録情報に基づき表示しています。 登録・更新については、
こちら
をご覧ください。
前のページに戻る
TOP
BOTTOM
